TrialBritish journal of haematology2018

Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.

Jeffrey Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.